In the late 90’s, our founders started with a simple but profound question: Can the explosion of genetic and genomic data be transformed into computer models of disease progression and drug response? Can those models reveal new drug targets and new drugs and markers of response to enable personalized medicine? Can breakthroughs in machine learning, modeling, and simulation combined with ever increasing super-computing power turn this dream into a reality and transform the treatment of diseases such as cancer, diabetes, Alzheimer’s, heart disease, multiple sclerosis?
Those were the questions that led Colin Hill and Dr. Iya Khalil to start GNS Healthcare in 2000 out of Cornell University. The technology is built on the work Dr. Stuart Kauffman (5-time MacArthur “Genius” Award winner), Dr. Judea Pearl (winner of the Turing Award), and the fields of systems biology, chaos theory, statistical physics, artificial intelligence, and Bayesian statistics.
Today the mission of GNS has broadened but the vision has stayed largely the same: leveraging the latest innovations in machine learning, computing, and mathematics to turn biomedical and healthcare data into solutions and treatments that dramatically reduce the burden of human disease.